Circulation, Vol 67, 1296-1303, Copyright © 1983 by American Heart Association
AC Pernot, JS Ingwall, P Menasche, C Grousset, M Bercot, A Piwnica and ET Fossel
Hypothermic potassium cardioplegia is now commonly used to protect the
myocardium during surgically induced ischemia. Because the potassium-
related membrane depolarization has been shown to increase calcium influx,
we undertook this study to define the effects of varying the calcium
content in hyperkalemic perfusates and the effects of using magnesium
instead of or in addition to potassium as the arresting agent on the
ability of hearts to recover normal function after ischemic arrest. We
subjected isolated perfused working rat hearts to 60 minutes of
cardioplegic arrest followed by 30 minutes of reperfusion, and measured
high-energy phosphate levels every 2 1/2 minutes by phosphorus- 31 nuclear
magnetic resonance spectroscopy. These data were correlated with
postischemic recovery of function. Our results show that potassium
cardioplegia may be harmful when the calcium concentration is greater than
1 mM. The kalemic injury is significantly reduced when the calcium content
is lowered to 0.25 mM and the greatest extent of preservation is provided
by a calcium-poor perfusate (0.25 mM) containing 13 mM magnesium. The
beneficial effects of magnesium are not enhanced by subsequent addition of
potassium. Close correlations were found between all observed metabolic
changes during arrest and the degree of recovery of contractile performance
after reperfusion. We conclude that the ability of the myocardium to
maintain or resynthesize high-energy phosphate after cardioplegic arrest
may be an important determinant of postischemic mechanical performance.
These results show that phosphorus- 31 nuclear magnetic resonance
spectroscopy is a valuable method for evaluating interventions to reduce
the severity of ischemic damage.
ARTICLES
Evaluation of high-energy phosphate metabolism during cardioplegic arrest and reperfusion: a phosphorus-31 nuclear magnetic resonance study
This article has been cited by other articles:
![]() |
J. O. Van Dobbenburgh, J. R. Lahpor, S. R. Woolley, N. de Jonge, C. Klopping, and C. J.A. Van Echteld Functional Recovery After Human Heart Transplantation Is Related to the Metabolic Condition of the Hypothermic Donor Heart Circulation, December 1, 1996; 94(11): 2831 - 2836. [Abstract] [Full Text] |
||||
![]() |
G. Pinelli, P.-M. Mertes, J.-P. Carteaux, Y. Jaboin, J.-M. Escanye, F. Brunotte, and J.-P. Villemot Myocardial Effects of Experimental Acute Brain Death: Evaluation by Hemodynamic and Biological Studies Ann. Thorac. Surg., December 1, 1995; 60(6): 1729 - 1734. [Abstract] [Full Text] |
||||
![]() |
P. Bottomley Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy Science, August 23, 1985; 229(4715): 769 - 772. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |